chr10-34111165-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The ENST00000374788.8(PARD3):c.*4C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0205 in 1,534,906 control chromosomes in the GnomAD database, including 399 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.016 ( 25 hom., cov: 32)
Exomes 𝑓: 0.021 ( 374 hom. )
Consequence
PARD3
ENST00000374788.8 3_prime_UTR
ENST00000374788.8 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0280
Genes affected
PARD3 (HGNC:16051): (par-3 family cell polarity regulator) This gene encodes a member of the PARD protein family. PARD family members interact with other PARD family members and other proteins; they affect asymmetrical cell division and direct polarized cell growth. Multiple alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 10-34111165-G-A is Benign according to our data. Variant chr10-34111165-G-A is described in ClinVar as [Benign]. Clinvar id is 3056597.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0159 (2418/152284) while in subpopulation NFE AF= 0.0235 (1601/68030). AF 95% confidence interval is 0.0226. There are 25 homozygotes in gnomad4. There are 1191 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2418 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARD3 | NM_001184785.2 | c.*4C>T | 3_prime_UTR_variant | 25/25 | ENST00000374788.8 | NP_001171714.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARD3 | ENST00000374788.8 | c.*4C>T | 3_prime_UTR_variant | 25/25 | 1 | NM_001184785.2 | ENSP00000363920 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0159 AC: 2418AN: 152166Hom.: 25 Cov.: 32
GnomAD3 genomes
AF:
AC:
2418
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0168 AC: 3384AN: 201472Hom.: 38 AF XY: 0.0172 AC XY: 1874AN XY: 109154
GnomAD3 exomes
AF:
AC:
3384
AN:
201472
Hom.:
AF XY:
AC XY:
1874
AN XY:
109154
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0210 AC: 29065AN: 1382622Hom.: 374 Cov.: 31 AF XY: 0.0208 AC XY: 14120AN XY: 678958
GnomAD4 exome
AF:
AC:
29065
AN:
1382622
Hom.:
Cov.:
31
AF XY:
AC XY:
14120
AN XY:
678958
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0159 AC: 2418AN: 152284Hom.: 25 Cov.: 32 AF XY: 0.0160 AC XY: 1191AN XY: 74460
GnomAD4 genome
AF:
AC:
2418
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
1191
AN XY:
74460
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
19
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PARD3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 20, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at